PS
AVNS icon

Principal Securities’s Avanos Medical AVNS Stock Holding History

Principal Securities’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$58 – 1516
2025
Q3 		$58 Sell
5
-169
-97% -$1.98K ﹤0.01% 3718
2025
Q2 		$2.13K Sell
174
-20
-10% -$252 ﹤0.01% 3127
2025
Q1 		$3.09K Hold
194
– – ﹤0.01% 2931
2024
Q4 		$3.09K Buy
194
+33
+20% +$653 ﹤0.01% 2927
2024
Q3 		$3.87K Hold
161
– – ﹤0.01% 2758
2024
Q2 		$3.21K Buy
161
+20
+14% +$390 ﹤0.01% 2783
2024
Q1 		$2.81K Buy
141
+5
+4% +$97 ﹤0.01% 2774
2023
Q4 		$3.05K Buy
+136
New +$2.81K ﹤0.01% 2697

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Securities's AVNS Position: Q4 2025 in Review

Principal Securities sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 5 shares — an estimated $58 sold.

Principal Securities first reported a position in AVNS in Q4 2023 and held it in 8 quarters. The position peaked at $3.87K in Q3 2024. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Principal Securities reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 5 Avanos Medical shares in Q4 2025, an estimated $58.
  • Principal Securities first reported a position in Avanos Medical in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Avanos Medical position peaked at $3.87K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.